Tracheal and Bronchial Surgery

Total Page:16

File Type:pdf, Size:1020Kb

Tracheal and Bronchial Surgery Tracheal and Bronchial Surgery 1A031 Honorary Editors: Douglas E. Wood, Douglas J. Mathisen, Erino Angelo Rendina Editors: Xiaofei Li, Federico Venuta, David C. van der Zee Associate Editors: Dirk Van Raemdonck, Federico Rea, Jinbo Zhao Xiaofei Li, Federico Venuta, David C. van der Zee Xiaofei Li, Federico Venuta, Editors: Tracheal and Bronchial Surgery Honorary Editors: Douglas E. Wood, Douglas J. Mathisen, Erino Angelo Rendina Editors: Xiaofei Li, Federico Venuta, David C. van der Zee Associate Editors: Dirk Van Raemdonck, Federico Rea, Jinbo Zhao AME Publishing Company Room C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong Information on this title: www.amegroups.com For more information, contact [email protected] Copyright © AME Publishing Company. All rights reserved. This publication is in copyright. Subject to statutory exception and to the provisions of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of AME Publishing Company. First published 2017 Printed in China by AME Publishing Company Editors: Xiaofei Li, Federico Venuta, David C. van der Zee Cover Image Illustrator: Zhijing Xu, Shanghai, China Tracheal and Bronchial Surgery Hardcover ISBN: 978-988-77841-8-0 AME Publishing Company, Hong Kong AME Publishing Company has no responsibility for the persistence or accuracy of URLs for external or third-party internet websites referred to in this publication, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. The advice and opinions expressed in this book are solely those of the author and do not necessarily represent the views or practices of AME Publishing Company. No representations are made by AME Publishing Company about the suitability of the information contained in this book, and there is no consent, endorsement or recommendation provided by AME Publishing Company, express or implied, with regard to its contents. Tracheal and Bronchial Surgery I (FIRST EDITION) HONORARY EDITORS AUTHORS Douglas E. Wood Sanchit Ahuja The Henry N. Harkins Professor and Chair Department of Outcomes Research, Anesthesiology Department of Surgery, University of Washington, USA Institute, Cleveland Clinic, Cleveland, Ohio, USA Douglas J. Mathisen Jia An Massachusetts General Hospital, Boston, MA 02114, USA Singapore Centre for 3D Printing, School of Mechanical & Aerospace Engineering, Nanyang Technological Erino Angelo Rendina University, Singapore, Singapore Department of Thoracic Surgery, Sant’Andrea Hospital, Sapienza University, Rome, Italy Marco Anile University of Rome Sapienza, Rome, Italy; Department of Thoracic Surgery, Umberto I Hospital, Rome, Italy CO-EDITORS Hugh G. Auchincloss Xiaofei Li Division of Cardiothoracic Surgery, Massachusetts General Department of Thoracic Surgery, Tangdu Hospital, The Hospital, Boston, MA 02114, USA Fourth Military Medical University, Xi’an 710038, China Alper Avci Federico Venuta Department of Thoracic Surgery, Çukurova University Department of Thoracic Surgery, University of Rome Faculty of Medicine, Adana, Turkey Sapienza, Rome, Italy Montserrat Blanco Ramos David C. van der Zee Thoracic Surgery Department, Alvaro Cunqueiro Department of Pediatric Surgery, Wilhelmina Children’s University Clinical Hospital, EOXI Vigo, Spain Hospital, University Medical Center Utrecht, Utrecht, The Netherlands Maribel Botana-Rial Pneumology Department, Alvaro Cunqueiro University Clinical Hospital, EOXI Vigo, Spain ASSOCIATE EDITORS Elisa Brandigi Dirk Van Raemdonck Department of Medical Sciences, Surgery and Neurosciences, Department of Thoracic Surgery, University Hospital Clinic Pediatric Surgery, University of Siena, Siena, Italy Leuven, Herestraat, 3000 Leuven, Belgium Daniel H. Buitrago Federico Rea Division of Thoracic Surgery and Interventional Department of Cardio-Thoracic and Vascular Sciences, Pulmonology, Beth Israel Deaconess Medical Center, University of Padua, Padua, Italy Harvard Medical School, Boston, Massachusetts 02215, USA Jinbo Zhao Tayfun Caliskan Department of Thoracic Surgery, Tangdu Hospital, The Pulmonary Division, Haydarpasa Sultan Abdulhamid, Fourth Military Medical University, Xi’an 710038, China Training and Research Hospital, The University of Health Sciences, Istanbul, Turkey © AME Publishing Company. All rights reserved. www.amegroups.com II Tiesheng Cao Antonio D’Andrilli Department of Diagnostic Ultrasound, Tangdu Hospital, the Department of Thoracic Surgery, Sant’Andrea Hospital, Fourth Military Medical University, Xi’an 710038, China Sapienza University, Rome, Italy Cetin Celenk Eduardo de Miguel Poch Department of Radiology, Faculty of Medicine, Ondokuz Respiratory Department, 12 de Octubre University Mayis University, Samsun, Turkey Hospital, Madrid, Spain Chee Kai Chua Pierre Delaere Singapore Centre for 3D Printing, School of Mechanical Department of ENT, Head & Neck Surgery, University & Aerospace Engineering, Nanyang Technological Hospital Leuven, 3000 Leuven, Belgium University, Singapore, Singapore Jean Deslauriers Fu-Tsai Chung Division of Thoracic Surgery, Institut Universitaire de Department of Thoracic Medicine, Saint Paul’s Hospital, Cardiologie et de Pneumologie de Québec (IUCPQ), Taoyuan, Taiwan, China; College of Medicine Chang Quebec City, Que, G1V 4G5, Canada Gung University, Taoyuan, Taiwan, China; Department of Thoracic Medicine, Chang Gung Memorial Hospital at Alain Didier Linkou, Taoyuan, Taiwan, China Pulmonology Department, Larrey University Hospital, Toulouse, France Aliza P. Cohen Division of Pediatric Otolaryngology-Head and Neck Pierre Diemunsch Surgery, Cincinnati Children’s Hospital Medical Center, Department of Anaesthesia and Intensive Care Medicine, Cincinnati, OH, USA University Hospitals of Hautepierre, Strasburg, France Barak Cohen Daniele Diso Department of Outcomes Research, Anesthesiology University of Rome Sapienza, Rome, Italy; Department of Institute, Cleveland Clinic, Cleveland, Ohio, USA Thoracic Surgery, Umberto I Hospital, Rome, Italy Massimo Conti Jennifer Dixon Division of Thoracic Surgery, Institut Universitaire de Division of Cardiothoracic Surgery, Oregon Health and Cardiologie et de Pneumologie de Québec (IUCPQ), Science University, Portland, Oregon, USA Quebec City, Que, G1V 4G5, Canada Qinglong Dong Joel D. Cooper Guangzhou Research Institute of Respiratory Disease, Division of Thoracic Surgery, University of Pennsylvania China State Key Laboratory of Respiratory Disease, Health System, Philadelphia, PA 19104, USA Guangzhou 510120, China; National Centre for Clinical Trials on Respiratory Diseases, Guangzhou 510120, China; Christina L. Costantino Department of Anesthesiology, the First Af liated Hospital Massachusetts General Hospital, Boston, MA 02114, USA of Guangzhou Medical University, Guangzhou 510120, China Fei Cui Department of Thoracic Surgery, the First Affiliated Gabrielle Drevet Hospital of Guangzhou Medical University, Guangzhou Division of Thoracic Surgery, Institut Universitaire de 510120, China; Guangzhou Research Institute of Respiratory Cardiologie et de Pneumologie de Québec (IUCPQ), Disease, China State Key Laboratory of Respiratory Disease, Quebec City, Que, G1V 4G5, Canada Guangzhou 510120, China; National Centre for Clinical Trials on Respiratory Diseases, Guangzhou 510120, China © AME Publishing Company. All rights reserved. www.amegroups.com III Sylvain Droneau Nicolas Guibert Pulmonology Department, Larrey University Hospital, Pulmonology Department, Larrey University Hospital, Toulouse, France Toulouse, France Muzaffer Elmali Ting Guo Department of Radiology, Faculty of Medicine, Ondokuz Department of Thoracic Surgery, Tangdu Hospital, the Mayis University, Samsun, Turkey Fourth Military Medical University, Xi’an 710038, China Ricardo Fernandez Yong Han Department of Thoracic Surgery and Minimally Invasive Department of Thoracic Surgery, Tangdu Hospital, Fourth Thoracic Surgery Unit (UCTMI), Coruña University Military Medical University, Xi’an 710038, China Hospital, 15006 Coruña, Spain Zehra Hatipoglu Alberto Fernández-Villar Department of Anesthesiology and Reanimation, Çukurova Pneumology Department, Alvaro Cunqueiro University University Faculty of Medicine, Adana, Turkey Clinical Hospital, EOXI Vigo, Spain Jiaxi He Henning A. Gaissert Department of Thoracic Surgery, the First Affiliated Division of Thoracic Surgery, Department of Surgery, Hospital of Guangzhou Medical University, Guangzhou Massachusetts General Hospital, Boston, MA 02114, USA 510120, China; Guangzhou Research Institute of Respiratory Disease, China State Key Laboratory of Mercedes Gallas Torreira Respiratory Disease, Guangzhou 510120, China; National Senior Lecturer in Comprehensive Adult Dental Care, Centre for Clinical Trials on Respiratory Diseases, Faculty of Medicine and Dentistry, University of Santiago Guangzhou 510120, China de Compostela, A Coruña, Spain Jianxing He Sidhu P. Gangadharan Department of Thoracic Surgery, the First Affiliated Division of Thoracic Surgery and Interventional Hospital of Guangzhou Medical University, Guangzhou Pulmonology, Beth Israel Deaconess Medical Center, 510120, China; Guangzhou Research Institute of Harvard Medical School, Boston, Massachusetts 02215, Respiratory Disease, China State Key Laboratory of USA Respiratory Disease, Guangzhou 510120, China; National Centre for Clinical Trials on Respiratory Diseases, Eva García-Fontán Guangzhou 510120, China Thoracic Surgery Department, Alvaro Cunqueiro University Clinical Hospital, EOXI
Recommended publications
  • Respiratory Therapy Program
    UNIVERSITY OF THE DISTRICT OF COLUMBIA RESPIRATORY THERAPY PROGRAM The University offers the A.A.S. Degree in Respiratory ASSOCIATE IN APPLIED SCIENCE DEGREE IN Therapy. The curriculum reflects high standards of RESPIRATORY THERAPY professional practice and incorporates guidelines from practice trends, professional organizations and accrediting Total Credit Hours of College-Level Courses Required agencies. Students develop the knowledge base and For Graduation: 70 clinical competencies required to meet the health care needs of patients with cardiopulmonary disorders. The program offers both a day and an evening option. Respiratory Therapists treat patients along the age and health-care continuums – from premature infants to the PROGRAM OF STUDY aged in critical care, acute care, rehabilitation, and home care settings. PREREQUISITES 1535-101 General College Math I 3 ACCREDITATION & CREDENTIALING 1133-111 English Composition I 3 1401-112 Anatomy and Physiology II – Lecture 3 The UDC Respiratory Therapy Program is accredited by 1401-114 Anatomy and Physiology II – Lab 1 the Commission on Accreditation of Allied Health Total 10 Credits Education Programs (CAAHEP), in collaboration with the FIRST YEAR – FALL SEMESTER Committee on Accreditation for Respiratory Care 1431-170 Introduction to Health Sciences 2 1431-171 Principles and Practice of Resp Therapy I 4 (CoARC). Graduates are eligible for both the entry-level licensure/ CRT examination (required by the District of 1401-112 Anatomy and Physiology II – Lecture 3 Columbia, Maryland and Virginia) and the advanced 1401-114 Anatomy and Physiology II – Lab 1 1133-112 or 1535-102 English Composition II or practice RRT examinations, both offered by the National Board for Respiratory Care (NBRC).
    [Show full text]
  • Diagnostic Issues in Systemic Lupus Erythematosis
    266 Postgrad Med J 2001;77:266–285 Postgrad Med J: first published as 10.1136/pmj.77.906.268 on 1 April 2001. Downloaded from SELF ASSESSMENT QUESTIONS Diagnostic issues in systemic lupus erythematosis N Sofat, C Higgens Answers on p 274. A 24 year old woman was diagnosed with sys- (4) What other tests (apart from 24 hour urine temic lupus erythematosis (SLE) based on a creatinine clearance) are available to measure few months’ history of a photosensitive skin the glomerular filtration rate? rash, predominantly on her face, arthralgia The patient had a 24 hour urinary protein col- involving both hands and wrists, a positive lection, which showed a 24 hour protein measure- antinuclear antibody (ANA) test and a raised ment of 1.8 g. There was no evidence of cellular antinative double stranded DNA antibody casts on urine microscopy. Her blood results were binding level. She was treated with oral as below (normal values are in parentheses): hydroxychloroquine 400 mg daily and short x Sodium 134 mmol/l (135–145) courses of prednisolone during flare-ups. x Potassium 4.5 mmol/l (3.5–5.0) She was reviewed in clinic for her regular x Urea 7.0 mmol/l (2.5–6.7) follow up appointment when she was found to x Creatinine 173 µmol/l (70–115) be hypertensive on repeated measurements of x Haemoglobin 108 g/l (115–160) her blood pressure, an average value being x White cell count 4.5 × 109/l (4.0–11.0) 150/90 mm Hg. She was also urine dipstick x Platelets 130 × 109/l (150–400) positive for blood and protein.
    [Show full text]
  • Unusual Case of Non-Resolving Necrotizing Pneumonia: a Last Resort Measure for Cure
    eCommons@AKU Department of Surgery Department of Surgery June 2016 Unusual case of non-resolving necrotizing pneumonia: a last resort measure for cure. Naseem Salahuddin Aga Khan University, [email protected] Naila Baig Ansari Aga Khan University Saulat H. Fatimi Aga Khan University, [email protected] Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg Part of the Surgery Commons Recommended Citation Salahuddin, N., Ansari, N., Fatimi, S. (2016). Unusual case of non-resolving necrotizing pneumonia: a last resort measure for cure.. JPMA: Journal of the Pakistan Medical Association, 66(6), 754-756. Available at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/566 754 CASE REPORT Unusual case of non-resolving necrotizing pneumonia: A last resort measure for cure Naseem Salahuddin, 1 Naila Baig-Ansari, 2 Saulat Hasnain Fatimi 3 Abstract pathogen of acute CAP, 2,3 and accounts for most cases of To our knowledge, this is an unusual case of a community- slowly resolving pneumonia.The majority of previously acquired pneumonia (CAP) with sepsis secondary to healthy hospitalized patients with severe CAP responded Streptococcus pneumoniae that required lung resection satisfactorily to prompt initiation of appropriate antibiotic for a non-resolving consolidation. A 74 year old previously therapy; however, it is estimated that 10% of hospitalized healthy woman, presented with acute fever, chills and CAP patients have slowly resolving or nonresolving pleuritic chest pain in Emergency Department (ED). A disease. 4 diagnosis of CAP was established with a Pneumonia Severity Index CURB-65 score of 5/5. In the ER, she was Case Report promptly and appropriately managed with antibiotics History: A 74 year old woman who was previously and aggressive supportive therapy.
    [Show full text]
  • Nonintubated Thoracoscopic Surgery Using Regional Anesthesia and Vagal Block and Targeted Sedation
    Original Article Nonintubated thoracoscopic surgery using regional anesthesia and vagal block and targeted sedation Ke-Cheng Chen1,2, Ya-Jung Cheng3, Ming-Hui Hung3, Yu-Ding Tseng1, Jin-Shing Chen1,2 1Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin County, Taiwan; 2Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 3Department of Anesthesiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan Corresponding to: Dr. Jin-Shing Chen. Department of Surgery, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei, Taiwan. Email: [email protected]. Objective: Thoracoscopic surgery without endotracheal intubation is a novel technique for diagnosis and treatment of thoracic diseases. This study reported the experience of nonintubated thoracoscopic surgery in a tertiary medical center in Taiwan. Methods: From August 2009 through August 2013, 446 consecutive patients with lung or pleural diseases were treated by nonintubated thoracoscopic surgery. Regional anesthesia was achieved by thoracic epidural anesthesia or internal intercostal blockade. Targeted sedation was performed with propofol infusion to achieve a bispectral index value between 40 and 60. The demographic data and clinical outcomes were evaluated by retrospective chart review. Results: Thoracic epidural anesthesia was used in 290 patients (65.0%) while internal intercostal blockade was used in 156 patients (35.0%). The final diagnosis were primary lung cancer in 263 patients (59.0%), metastatic lung cancer in 38 (8.5%), benign lung tumor in 140 (31.4%), and pneumothorax in 5 (1.1%). The median anesthetic induction time was 30 minutes by thoracic epidural anesthesia and was 10 minutes by internal intercostal blockade.
    [Show full text]
  • Your Lung Operation Booklet
    1 AMERICAN COLLEGE OF SURGEONS DIVISION OF EDUCATION SURGICAL PATIENT EDUCATION Table of Contents Welcome ...................................................................................1 Your Lungs ...............................................................................2 Lung Cancer ...........................................................................3 SURGICAL Understanding Your Operation ........................................4 PATIENT Preoperative Tests ................................................................5 EDUCATION Home Preparation ................................................................8 The Day of Your Operation ...............................................13 After Your Operation ..........................................................14 Your Recovery and Discharge .........................................17 When to Call Your Doctor .................................................19 Welcome You and your family are important members of the surgical team. The American College of Surgeons (ACS) “Your Lung Operation: Education for a Better Recovery” program will help you prepare for your operation and recovery. You and your family will know what to expect. You will learn how to work with your surgical team to ensure that you have the best surgical outcomes. COMPLETE THE “YOUR LUNG OPERATION” EDUCATION PROGRAM: Watch the DVD Read the booklet Review the Medication List and Quit Smoking Resources (inside front cover) Complete the Activity Log (inside front cover) Send us your evaluation after
    [Show full text]
  • Toman's Tuberculosis Case Detection, Treatment, and Monitoring
    TOMAN’S TUBERCULOSIS TOMAN’S TUBERCULOSIS CASE DETECTION, TREATMENT, AND MONITORING The second edition of this practical, authoritative reference book provides a rational basis for the diagnosis and management of tuberculosis. Written by a number of experts in the field, it remains faithful to Kurt Toman’s original question-and-answer format, with subject matter grouped under the three headings Case detection, Treatment, and Monitoring. It is a testament to the enduring nature of the first edition that so much CASE DETECTION, TREA material has been retained unchanged. At the same time, the new edition has had not only to address the huge resurgence of tuber- culosis, the emergence of multidrug-resistant bacilli, and the special needs of HIV-infected individuals with tuberculosis, but also to encompass significant scientific advances. These changes in the profile of the disease and in approaches to management have inevitably prompted many new questions and answers and given a different complexion to others. Toman’s Tuberculosis remains essential reading for all who need to AND MONITORING TMENT, QUESTIONS learn more about every aspect of tuberculosis – case-finding, manage- ment, and effective control strategies. It provides invaluable support AND to anyone in the front line of the battle against this disease, from ANSWERS programme managers to policy-makers and from medical personnel to volunteer health workers. SECOND EDITION ISBN 92 4 154603 4 WORLD HEALTH ORGANIZATION WHO GENEVA Toman’s Tuberculosis Case detection, treatment, and monitoring – questions and answers SECOND EDITION Edited by T. Frieden WORLD HEALTH ORGANIZATION GENEVA 2004 WHO Library Cataloguing-in-Publication Data Toman’s tuberculosis case detection, treatment, and monitoring : questions and answers / edited by T.
    [Show full text]
  • The Diseases of Airway-Tracheal Diverticulum: a Review of the Literature
    Review Article The diseases of airway-tracheal diverticulum: a review of the literature Asli Tanrivermis Sayit, Muzaffer Elmali, Dilek Saglam, Cetin Celenk Department of Radiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey Contributions: (I) Conception and design: A Tanrivermis Sayit; (II) Administrative support: M Elmali, C Celenk; (III) Provision of study materials or patients: A Tanrivermis Sayit; (IV) Collection and assembly of data: A Tanrivermis Sayit, D Saglam; (V) Data analysis and interpretation: A Tanrivermis Sayit, M Elmali, C Celenk; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Asli Tanrivermis Sayit. Department of Radiology, Faculty of Medicine, Ondokuz Mayis University, 55139, Atakum/Samsun, Turkey. Email: [email protected]. Abstract: Tracheal diverticulum (DV) is a type of paratracheal air cyst (PTAC) that is often asymptomatic and usually detected incidentally by imaging methods. Tracheal DV are divided into two subgroups: congenital and acquired. Dysphagia, odynophagia, neck pain, hoarseness, hemoptysis, choking, and recurrent episodes of hiccups and burping can also be seen in symptomatic patients. Thin-section multidetector computed tomography (MDCT) is useful for diagnosis of tracheal diverticulum. The relationship between DV and tracheal lumen can be demonstrated by axial, coronal, and sagittal reformat multiplanar images. Bronchoscopy can also be used in diagnosis for tracheal DV. However, the connection between DV and tracheal lumen can not be shown easily with bronchoscopy. Conservative treatment is the preferred treatment in asymptomatic patients. Surgical or conservative treatment can be performed for symptomatic patients, depending on patient age and physical condition. Keywords: Trachea; diverticulum (DV); thorax; multidetector computed tomography; tracheal diseases; chronic obstructive pulmonary disease (CODP) Submitted Sep 17, 2016.
    [Show full text]
  • PQI 15 Asthma in Younger Adults Admission Rate
    AHRQ Quality Indicators™ (AHRQ QI™) ICD-10-CM/PCS Specification v2021 Prevention Quality Indicator 15 (PQI 15) Asthma in Younger Adults Admission Rate July 2021 Area-Level Indicator Type of Score: Rate Prepared by: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services www.qualityindicators.ahrq.gov DESCRIPTION Admissions for a principal diagnosis of asthma per 100,000 population, ages 18 to 39 years. Excludes admissions with an indication of cystic fibrosis or anomalies of the respiratory system, obstetric admissions, and transfers from other institutions. [NOTE: The software provides the rate per population. However, common practice reports the measure as per 100,000 population. The user must multiply the rate obtained from the software by 100,000 to report admissions per 100,000 population.] NUMERATOR Discharges, for patients ages 18 through 39 years, with a principal ICD-10-CM diagnosis code for asthma (ACSASTD*). [NOTE: Obstetric discharges are not included in the PQI rate for PQI 15, though the AHRQ QI™ does not explicitly exclude obstetric cases. By definition, discharges with a principal diagnosis of asthma exclude obstetric discharges, because the principal diagnosis for an obstetric discharge would identify it as obstetric, and no such diagnoses are included in the set of qualifying diagnoses.] July 2021 1 of 5 AHRQ QI™ ICD-10-CM/PCS Specification v2021 PQI 15 Asthma in Younger Adults Admission Rate www.qualityindicators.ahrq.gov NUMERATOR EXCLUSIONS Exclude cases: • with any listed ICD-10-CM
    [Show full text]
  • Translational Deep Phenotyping of Deaths Related to the COVID-19 Pandemic: Protocol for a Prospective Observational Autopsy Study
    Open access Protocol BMJ Open: first published as 10.1136/bmjopen-2021-049083 on 27 August 2021. Downloaded from Translational deep phenotyping of deaths related to the COVID-19 pandemic: protocol for a prospective observational autopsy study Mikkel Jon Henningsen ,1 Apameh Khatam- Lashgari,1 Kristine Boisen Olsen,1 Christina Jacobsen,1 Christian Beltoft Brøchner ,2 Jytte Banner1 To cite: Henningsen MJ, ABSTRACT Strengths and limitations of this study Khatam- Lashgari A, Olsen KB, Introduction The COVID-19 pandemic is an international et al. Translational deep emergency with an extreme socioeconomic impact and a ► A standardised, prospective autopsy study on COVID- phenotyping of deaths high mortality and disease burden. The COVID-19 outbreak related to the COVID-19 19- related deaths with systematic data collection. is neither fully understood nor fully pictured. Autopsy studies pandemic: protocol for a ► A multidisciplinary, translational approach elucidat- can help understand the pathogenesis of COVID-19 and has prospective observational ing changes from protein level to whole human. already resulted in better treatment of patients. Structured autopsy study. BMJ Open ► A comprehensive biobank and extensive registry and systematic autopsy of COVID-19- related deaths will 2021;11:e049083. doi:10.1136/ data as an umbrella for planned and future research. bmjopen-2021-049083 enhance the mapping of pathophysiological pathways, not ► The internal control group partly compensates for possible in the living. Furthermore, it provides an opportunity Prepublication history and the observational design. ► to envision factors translationally for the purpose of disease additional supplemental material ► Limited by a selected sample of COVID-19 diseased prevention in this and future pandemics.
    [Show full text]
  • Table of Contents 1
    GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL August 2017 Table of Contents 1. Demographics ................................................................................................................................................................. 2 2. Follow Up ........................................................................................................................................................................ 9 3. Admission ..................................................................................................................................................................... 10 4. Pre-Operative Evaluation ............................................................................................................................................. 14 5. Diagnosis (Category of Disease) ................................................................................................................................... 48 6. Procedure ..................................................................................................................................................................... 70 7. Post-Operative Events ................................................................................................................................................ 111 8. Discharge .................................................................................................................................................................... 135 9. Quality Measures ......................................................................................................................................................
    [Show full text]
  • Identification of Two Novel LAMP2 Gene Mutations in Danon Disease
    The Laryngoscope © 2016 the American Laryngological, Rhinological and Otological Society, Inc. Rotational Thyrotracheopexy After Cricoidectomy for Low-Grade Laryngeal Chrondrosarcoma László Rovó, MD, PhD; Ádám Bach, MD; Balázs Sztanó, MD, PhD; Vera Matievics, MD; Ilona Szegesdi, MD; Paul F. Castellanos, MD, FCCP Objectives:The complex laryngeal functions are fundamentally defined by the cricoid cartilage. Thus, lesions requiring subtotal or total resection of the cricoid cartilage commonly warrant total laryngectomy. However, from an oncological per­ spective, the resection of the cricoid cartilage would be an optimal solution in these cases. The poor functional results of the few reported cases of total and subtotal cricoidectomy with different reconstruction techniques confirm the need for new approaches to reconstruct the infrastructure of the larynx post cricoidectomy. Study Design:Retrospective case series review. Methods:Four consecutive patients with low-grade chondrosarcoma were treated by cricoidectomy with rotational thy­ rotracheopexy reconstruction to enable the functional creation of a complete cartilaginous ring that can substitute the func­ tions of the cricoid cartilage. The glottic structures were stabilized with endoscopic arytenoid abduction lateropexy. Patients were evaluated with objective and subjective function tests. Results: Tumor-free margins were proven; patients were successfully decannulated within 3 weeks. Voice outcomes were adequate for social conversation in all cases. Oral feeding was possible in three patients. Conclusion:Total and subtotal cricoidectomy can be a surgical option to avoid total laryngectomy in cases of large chondrosarcomas destroying the cricoid cartilage. The thyrotracheopexy rotational advancement technique enables the effec­ tive reconstruction of the structural deficit of the resected cricoid cartilage in cases of total and subtotal cricoidectomy.
    [Show full text]
  • Respiratory Therapy Handbook
    WASHINGTON STATE COMMUNITY COLLEGE RESPIRATORY THERAPY STUDENT HANDBOOK 2020-2021 Written: July, 1996 Revised: December, 2020 TABLE OF CONTENTS Statement of Non-Discrimination…………………………………………………………………………….. 2 Introduction……………………………………………………………………………………………………………..3 Goal………………………………………………………………………………………………………………………5-6 Accreditation……………………………………………………………………………………………………………6 Program Organization………………………………………………………………………………………………7 Plan for Consistency of Clinical Instruction & Evaluation of Clinical courses, Preceptors & Clinical Sites…………………………………………………………………………………………………………9 STUDENT POLICIES Course of Study………………………………………………………………………………………………………11 Student Schedule/Class sessions……………………………………………………………………………..11 Clinical Experiences…………………………………………………………………………………………..11-12 Tardiness……………………………………………………………………………………………………………….12 Absenteeism, Clinical…………………………………………………………………………………………12-13 Absenteeism, Classroom………………………………………………………………………………………….13 Absenteeism, Lab……………………………………………………………………………………………….13-14 Clinical Evaluations……………………………………………………………………………………………15-16 Clinical Competency…………………………………………………………………………………………..17-20 ACADEMIC POLICIES Clinical Evaluation Forms…………………………………………………………………………………..15-16 Clinical Competency Evaluation………………………………………………………………………….17-20 Promotion………………………………………………………………………………………………………………21 Evaluation………………………………………………………………………………………………………………21 Remediation …………………………………………………………………………………………………………..22 Probation/Dismissal……………………………………………………………………………………………….22 Leave of Absence…………………………………………………………………………………………………….22
    [Show full text]